Drugs / Wockhardt's Insulin Analogue (Recomb)
Follow
re-read 3 minutes ago
Wockhardt's Insulin Analogue (Recomb)
also known as
Wockhardt's Recombinant Insulin Analogue
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01352663 | — | type 1 diabetes mellitus | Wockhardt | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wockhardt's Insulin Analogue (Recomb) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01352663 ↗ |
| Known as | Wockhardt's Recombinant Insulin Analogue | “Basal bolus Wockhardt's Recombinant Insulin Analogue to be injected subcutaneously.” NCT01352663 ↗ |
| Modality | Protein / enzyme biologic | “Basal bolus Wockhardt's Recombinant Insulin Analogue to be injected subcutaneously.” NCT01352663 ↗ |
| Route | Subcutaneous | “to be injected subcutaneously” NCT01352663 ↗ |